PRJEB1986: zebrafish developmental stages transcriptome
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
nrf1 | dr11_v1_chr4_-_15103646_15103696 | 0.73 | 4.1e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_41966854 Show fit | 11.38 |
ENSDART00000055709
|
hairy-related 2 |
|
chr16_-_7379328 Show fit | 11.10 |
ENSDART00000060447
|
mediator of RNA polymerase II transcription, subunit 18 homolog (yeast) |
|
chr24_+_42004640 Show fit | 9.73 |
ENSDART00000171380
|
DNA topoisomerase I mitochondrial |
|
chr17_-_20167206 Show fit | 9.10 |
ENSDART00000104874
ENSDART00000191995 |
prolyl 4-hydroxylase, alpha polypeptide I b |
|
chr20_-_46541834 Show fit | 7.91 |
ENSDART00000060685
ENSDART00000181720 |
transmembrane p24 trafficking protein 10 |
|
chr10_-_40826657 Show fit | 7.90 |
ENSDART00000076304
|
proliferating cell nuclear antigen |
|
chr17_+_24821627 Show fit | 7.75 |
ENSDART00000112389
|
WD repeat domain 43 |
|
chr6_-_9676108 Show fit | 7.66 |
ENSDART00000169915
|
NOP58 ribonucleoprotein homolog (yeast) |
|
chr17_+_37932706 Show fit | 7.59 |
ENSDART00000075941
|
pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 |
|
chr16_+_40575742 Show fit | 7.27 |
ENSDART00000161503
|
cyclin E2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 35.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 21.1 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.4 | 13.2 | GO:0001569 | patterning of blood vessels(GO:0001569) |
0.2 | 12.4 | GO:0034504 | protein localization to nucleus(GO:0034504) |
2.4 | 12.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.6 | 11.7 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) 4-hydroxyproline metabolic process(GO:0019471) |
1.9 | 11.4 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.1 | 11.0 | GO:0007030 | Golgi organization(GO:0007030) |
0.6 | 10.5 | GO:0034629 | cellular protein complex localization(GO:0034629) |
1.5 | 10.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 46.2 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 21.9 | GO:0005829 | cytosol(GO:0005829) |
2.7 | 16.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 15.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.2 | 14.5 | GO:0000779 | condensed chromosome, centromeric region(GO:0000779) |
0.0 | 13.8 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 13.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
1.8 | 12.8 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 12.6 | GO:0044428 | nuclear part(GO:0044428) |
0.3 | 12.4 | GO:0005643 | nuclear pore(GO:0005643) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 51.4 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 51.3 | GO:0003712 | transcription factor activity, transcription factor binding(GO:0000989) transcription cofactor activity(GO:0003712) |
0.0 | 42.7 | GO:0003723 | RNA binding(GO:0003723) |
0.3 | 17.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 16.6 | GO:0042393 | histone binding(GO:0042393) |
0.6 | 16.5 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 14.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.6 | 12.8 | GO:0030515 | snoRNA binding(GO:0030515) |
4.1 | 12.2 | GO:0016713 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
2.4 | 11.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 16.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.4 | 12.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 11.8 | PID BARD1 PATHWAY | BARD1 signaling events |
0.6 | 10.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.3 | 8.5 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 8.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.2 | 6.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 6.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.5 | 5.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.3 | 5.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 15.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 15.1 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.4 | 12.2 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.2 | 11.7 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 11.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.3 | 10.7 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.4 | 10.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.9 | 8.4 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.5 | 8.4 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.3 | 8.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |